Copenhagen, Denmark, February 12, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, announced that it will host a ...

OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the tragedy in Tumbler Ridge, B.C., and has launched the Tumbler Ridge Tragedy Appeal.

Ipsen reported US$88M of Iqirvo® net sales in PBC for 4Q25, bringing 2025 sales to US$208M, triggering the first commercial milestone payment to GENFIT ahead of schedule 1; Ipsen ...

Created by IPO-exited founders and operating globally, including London, New York, Berlin, Milan, Perth and Singapore, Founders Factory offers founders capital, operational support and unrivalled ...

Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, February 26, 2026, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during ...

Beacon Behavioral Partners (BBP), a physician-driven organization supporting a growing national network of independent psychiatric practices, today announced its newest partnership with Carolina ...

Idorsia will publish its Full Year 2025 Financial Reporting on Thursday February 26, at 07:00 CET. En cliquant sur ce lien, vous acceptez l'utilisation de cookies sur ce site internet. An investor ...

The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer. Optune Pax, developed by Novocure, is a ...

The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for ...

GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial ...

LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year First half fiscal 2026 revenue surpasses $2 million, up 36% year-over ...